Cardiovascular disease: Questioning the effect of β-blockers on vascular stiffness.
Division of Nephrology, Department of Medicine and Therapeutics, CUHK Carol &Richard Yu PD Research Centre, Prince of Wales Hospital, Chinese University of Hong Kong, 32 Ngan Shing Street, Shatin, N.T. Hong Kong, China.
Cheuk-Chun
CC
Szeto
Division of Nephrology, Department of Medicine and Therapeutics, CUHK Carol &Richard Yu PD Research Centre, Prince of Wales Hospital, Chinese University of Hong Kong, 32 Ngan Shing Street, Shatin, N.T. Hong Kong, China.
Philip Kam-Tao
PK
Li
D058671:Adrenergic beta-1 Receptor Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000628:therapy*; D017706:Lisinopril / Q000627:therapeutic use*; D008297:Male; D006435:Renal Dialysis; D059289:Vascular Stiffness / Q000187:drug effects*
D058671:Adrenergic beta-1 Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001262:Atenolol; D017706:Lisinopril